A CD44 monoclonal antibody differentially regulates CD11a/CD18 binding to intercellular adhesion molecules CD54, CD102 and CD50

Eur J Immunol. 1995 Sep;25(9):2460-4. doi: 10.1002/eji.1830250908.

Abstract

We have made a monoclonal anti-CD44 antibody which is able to activate the leukocyte integrin CD11a/CD18. Activated T cells strongly aggregated, and the aggregation was shown to be intercellular adhesion molecule (ICAM)-1 (CD54) and ICAM-2 (CD102) dependent. Using purified ICAM coated on plastic, only binding to ICAM-1 was increased by the CD44 antibody, whereas activation by phorbol ester increased binding to both ICAM-1 and ICAM-3. The binding to ICAM-2 was not affected by either treatment. These findings show that the CD11a/CD18 integrin can be activated in a ligand-specific manner by engagement of CD44.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / immunology
  • Antigens, CD / immunology*
  • Antigens, Differentiation*
  • CD11 Antigens / immunology*
  • Cell Adhesion Molecules / immunology*
  • Cell Aggregation / immunology
  • Cells, Cultured
  • Humans
  • Hyaluronan Receptors / immunology*
  • Intercellular Adhesion Molecule-1 / immunology*
  • Lymphocyte Activation / immunology
  • T-Lymphocytes / immunology*

Substances

  • Antibodies, Monoclonal
  • Antigens, CD
  • Antigens, Differentiation
  • CD11 Antigens
  • Cell Adhesion Molecules
  • Hyaluronan Receptors
  • ICAM2 protein, human
  • ICAM3 protein, human
  • Intercellular Adhesion Molecule-1